Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Purell is a leading brand of alcohol-based hand sanitizers and surface disinfectants, primarily utilizing ethyl alcohol (ethanol) as its active antimicrobial agent. Developed and manufactured by GOJO Industries, Purell products are designed for rapid hand hygiene and surface decontamination. The mechanism of action involves the denaturation of microbial proteins and the disruption of lipid membranes, providing broad-spectrum efficacy against many bacteria, fungi, and enveloped viruses. Beyond routine hand hygiene, Purell has been investigated in clinical trials for specialized topical applications, including the treatment of viral warts, herpes simplex virus (HSV-1) lesions, and the prevention of bacterial vaginosis recurrence in partners. It is also utilized in veterinary medicine for conditions such as canine superficial pyoderma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Purell.